A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin, John M Timmerman, Patrick J Stiff, Jonathan W Friedberg, Ian W Flinn, Andre Goy, Brian T Hill, Mitchell R Smith, Abhinav Deol, Umar Farooq, Peter McSweeney, Javier Munoz, Irit Avivi, Januario E Castro, Jason R Westin, Julio C Chavez, Armin Ghobadi, Krishna V Komanduri, Ronald Levy, Eric D Jacobsen, Thomas E Witzig, Patrick Reagan, Adrian Bot, John Rossi, Lynn Navale, Yizhou Jiang, Jeff Aycock, Meg Elias, David Chang, Jeff Wiezorek, William Y Go. N Engl J Med 2017
Times Cited: 1724




List of shared articles



Times cited


Next-generation CAR T cells to overcome current drawbacks.
Stefan Lundh, Sayantan Maji, J Joseph Melenhorst. Int J Hematol 2021
2

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.
Norihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, Masataka Suzuki. Mol Ther 2021
7

Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy.
Stella Bouziana, Dimitrios Bouzianas. Crit Rev Oncol Hematol 2021
2

Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.
Zhenyu Dai, Xuelian Hu, Xiangyin Jia, Jianwei Liu, Yongkun Yang, Panpan Niu, Guang Hu, Taochao Tan, Jianfeng Zhou. J Cell Physiol 2021
1

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma.
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri, Michael D Hogarty, David M Barrett, Hiroyuki Shimada, Shahab Asgharzadeh. Nat Commun 2021
6

Chimeric Antigen Receptor Design Today and Tomorrow.
Justin C Boucher, Marco L Davila. Cancer J 2021
0


CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities.
Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
2

Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models.
Dina Schneider, Ying Xiong, Darong Wu, Peirong Hu, Leah Alabanza, Brittany Steimle, Hasan Mahmud, Kim Anthony-Gonda, Winfried Krueger, Zhongyu Zhu,[...]. Sci Transl Med 2021
8

CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
12

Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells.
Ying Wang, Kailun Zhong, Jun Ke, Xi Chen, Yi Chen, Wangyun Shu, Chunhuan Chen, Shan Hu, Xiaoke Sun, Haibin Huang,[...]. Cytotherapy 2021
1

CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials.
Navin K Chintala, David Restle, Hue Quach, Jasmeen Saini, Rebecca Bellis, Michael Offin, Jason Beattie, Prasad S Adusumilli. Lung Cancer 2021
1

Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
Zhiliang Bai, Stefan Lundh, Dongjoo Kim, Steven Woodhouse, David M Barrett, Regina M Myers, Stephan A Grupp, Marcela V Maus, Carl H June, Pablo G Camara,[...]. J Immunother Cancer 2021
1


A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Marie Thérèse Rubio, Pauline Varlet, Vincent Allain, Caroline Ballot, Alexis Cuffel, Marina Deschamps, Christophe Ferrand, Jacques Foguenne, Edouard Forcade, Anne Huynh,[...]. Bull Cancer 2021
0

Immunotherapies in Non-Hodgkin's Lymphoma.
Christine Bezombes, Patricia Pérez-Galán. Cancers (Basel) 2021
0

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells.
Hongxia Wang, Liyan Wang, Yanning Li, Guangqi Li, Xiaochun Zhang, Dan Jiang, Yanting Zhang, Liyuan Liu, Yuankui Chu, Guangxian Xu. Cancer Cell Int 2021
0

Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function.
Alexander I Salter, Anusha Rajan, Jacob J Kennedy, Richard G Ivey, Sarah A Shelby, Isabel Leung, Megan L Templeton, Vishaka Muhunthan, Valentin Voillet, Daniel Sommermeyer,[...]. Sci Signal 2021
0

Chimeric antigen receptor T-cell therapy: An emergency medicine focused review.
Brit Long, Michael J Yoo, William J Brady, Angela Holian, Amita Sudhir, Michael Gottlieb. Am J Emerg Med 2021
0

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Bruno Martino, Maria Altomonte, Antonio Maria Rossetti, Giuseppa Cusumano, Letteria Russo,[...]. Expert Opin Biol Ther 2021
0

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy.
Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean-Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard,[...]. Cancers (Basel) 2021
0

Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Marianna Csaplár, János Szöllősi, Stephen Gottschalk, György Vereb, Árpád Szöőr. Cancers (Basel) 2021
0

Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh. Best Pract Res Clin Haematol 2021
0

Determinants of response and resistance to CAR T cell therapy.
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, Stefan Stoiber, Marion Subklewe, Stefan Endres, Sebastian Kobold. Semin Cancer Biol 2020
23

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells.
Bishwas Shrestha, Yongliang Zhang, Bin Yu, Gongbo Li, Justin C Boucher, Nolan J Beatty, Ho-Chien Tsai, Xuefeng Wang, Asmita Mishra, Kendra Sweet,[...]. J Immunother 2020
5

Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion.
Leonardo Chicaybam, Luiza Abdo, Mariana Viegas, Luisa Vieira Codeço Marques, Priscila de Sousa, Leonardo Ribeiro Batista-Silva, Viviane Alves-Monteiro, Simone Bonecker, Bárbara Monte-Mór, Martín Hernán Bonamino. Gene Ther 2020
11

Rapid and Effective Generation of Nanobody Based CARs using PCR and Gibson Assembly.
Stijn De Munter, Alexander Van Parys, Layla Bral, Joline Ingels, Glenn Goetgeluk, Sarah Bonte, Melissa Pille, Lore Billiet, Karin Weening, Annick Verhee,[...]. Int J Mol Sci 2020
5

CAR T cells and checkpoint inhibition for the treatment of glioblastoma.
Steven H Shen, Karolina Woroniecka, Andrew B Barbour, Peter E Fecci, Luis Sanchez-Perez, John H Sampson. Expert Opin Biol Ther 2020
11

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.
Sonia Guedan, Aviv Madar, Victoria Casado-Medrano, Carolyn Shaw, Anna Wing, Fang Liu, Regina M Young, Carl H June, Avery D Posey. J Clin Invest 2020
39